GridGain® Professional Edition 2.4 Introduces Integrated Machine Learning and Deep Learning in New Continuous Learning Framework, Adds Support for Apache® Spark(TM) DataFrames
New Continuous Learning Framework and Enhanced Spark Integration Can Power Real-Time Learning for Digital Transformation and Omnichannel Customer Experience Initiatives
FOSTER CITY, Calif., March 27, 2018 (GLOBE NEWSWIRE) -- GridGain Systems, provider of enterprise-grade in-memory computing solutions based on Apache® Ignite(TM), today announced the immediate availability of GridGain Professional Edition 2.4, a fully supported version of Apache Ignite 2.4. GridGain Professional Edition 2.4 now includes a Continuous Learning Framework, which includes machine learning and a multilayer perceptron (MLP) neural network that enable companies to run machine and deep learning algorithms against their petabyte-scale operational datasets in real-time. Companies can now build and continuously update models at in-memory speeds and with massive horizontal scalability. GridGain Professional Edition 2.4 also enhances the performance of Apache® Spark(TM) by introducing an API for Apache Spark DataFrames, adding to the existing support for Spark RDDs.
GridGain Continuous Learning Framework
GridGain Professional Edition 2.4 now includes the first fully supported release of the Apache Ignite integrated machine learning and multilayer perceptron features, making continuous learning using machine learning and deep learning available directly in GridGain. By optimizing these libraries for massively parallel processing (MPP) against the data residing in the GridGain cluster, large-scale machine learning use cases can be greatly accelerated. Processing data directly in the GridGain cluster enables a continuous learning workflow by eliminating the need to move transactional data into a separate database before model training. The result is real-time model training or even continuous model training with less complexity and substantially lower cost than traditional approaches.
The new GridGain Continuous Learning Framework is a building block for in-process HTAP (hybrid transactional/analytical processing) applications in which a data model is continually trained based on incoming data. In-process HTAP offers next-generation applications the ability to react to and benefit from real-time model training, which can power better real-time decision making in a wide range of business applications, such as fraud prevention, ecommerce recommendation engines, credit approvals, logistics, and transportation system maintenance decisions.
Expanded Support for Spark DataFrames
GridGain can now be used to store and manage Spark DataFrames. DataFrame support expands what was already the broadest support for Spark by any in-memory computing platform. GridGain continues to include the GridGain RDD API for accessing data in GridGain as mutable Spark RDDs, as well as the Ignite File System (IGFS) for using GridGain as an in-memory implementation of the Hadoop Distributed File System (HDFS).
Spark can be used to process data in GridGain as DataFrames or RDDs and also save DataFrames or RDDs into GridGain for later use. These capabilities allow GridGain to be used as in-memory storage by Spark developers to access, save and share information between Spark jobs. GridGain provides ANSI-99 SQL support, including data indexing, so Apache Spark can leverage GridGain's distributed SQL to improve ad hoc query performance up to 1000x. Spark developers can also leverage the GridGain Continuous Learning Framework to automate decisions and continually update models to improve outcomes in real-time.
"Companies wanting to automate more intelligent decision making need to harness the two sides of the digital brain - machine learning and decision automation - to continuously work together," said Abe Kleinfeld, President and CEO of GridGain Systems. "With this latest release, GridGain makes it possible to continuously train machine learning models in real-time on massive data sets at in-memory speed and scale, and with lower complexity and cost. This is the first step towards enabling in-process HTAP applications to drive continuous-learning applications that can power digital transformation and omnichannel customer experience initiatives."
About GridGain® Systems
GridGain Systems is revolutionizing real-time data access and processing by offering an in-memory computing platform built on Apache® Ignite(TM). GridGain solutions are used by global enterprises in financial, software, e-commerce, retail, online business services, healthcare, telecom and other major sectors, with a client list that includes Barclays, ING, Sberbank, Finastra, IHS Markit, Workday, and Huawei. GridGain delivers unprecedented speed and massive scalability to both legacy and greenfield applications. Deployed on a distributed cluster of commodity servers, GridGain software can reside between the application and data layers (RDBMS, NoSQL and Apache® Hadoop®), requiring no rip-and-replace of the existing databases, or it can be deployed as an in-memory transactional SQL database. GridGain is the most comprehensive in-memory computing platform for high-volume ACID transactions, real-time analytics, web-scale applications, continuous learning and HTAP. For more information, visit gridgain.com.
GridGain is a trademark or registered trademark of GridGain Systems, Inc. Apache, Apache Hadoop, Hadoop, Apache Ignite, Ignite, Apache Spark, and Spark, are trademarks of The Apache Software Foundation. All other product and company names herein may be trademarks of their registered owners.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: GridGain Systems via Globenewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Aryaka Names Cloud and Software Industry Veteran, Deepak Kumar, as Senior Vice President of Customer Success17.12.2018 15:00 | Pressemelding
SAN MATEO, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Aryaka®, the leading SD-WAN as a Service provider, announced today that Deepak Kumar, a 20-year cloud and enterprise software industry veteran, has joined the company’s leadership team as Senior Vice President, Customer Success. "We’re thrilled to welcome Deepak to Aryaka; his leadership will help us further enhance our end-user customer experience worldwide,” said Matt Carter, CEO of Aryaka. “His expertise in building and nurturing enterprise relationships will be critical as we continue to grow in 2019 and beyond.” Before joining Aryaka, Kumar was the SVP & GM at 7.ai, a Sequoia portfolio company in the customer experience domain. As SVP Business Development, he was responsible for building out strategic partnerships and alliances. His hard work grew the channel driven revenue significantly. As General Manager, Kumar was responsible for the Customer Acquisition Cloud product line. The product line was built based on strategic a
Biome Grow receives new consumer sales amendment from Health Canada for its Nova Scotia brand, Highland Grow17.12.2018 14:00 | Pressemelding
Sales amendment granted for Highland Grow—Amendment to License Significantly Increases Product Availability for Medical and Adult Consumer-Use Markets TORONTO, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Biome Grow Inc. (“Biome” or the “Company”) (CSE: BIO) (Frankfurt: 6OTA) (OTC: ORTFF) is pleased to announce its Nova Scotia-based subsidiary, Highland Grow Inc. (“Highland Grow”), has received its sales authorization via an amendment to its existing license from Health Canada under the Cannabis Act. This authorization will allow Highland Grow to sell cannabis products to end consumers through appropriate medical and recreational cannabis channels, dramatically increasing product availability. The sales authorization will position Biome Grow to serve the rapidly growing domestic and international cannabis markets. "Biome Grow has been steadfast in its focus on a regional business strategy and building provincial brands that can serve the unique requirements of its local cannabis consumers. This n
Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis17.12.2018 13:30 | Pressemelding
DUBLIN, Ireland and CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Alkermes plc (Nasdaq: ALKS) and Biogen Inc. (Nasdaq: BIIB) today announced that Alkermes has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for diroximel fumarate (BIIB098), a novel oral fumarate in development for the treatment of relapsing forms of multiple sclerosis (MS). Alkermes is seeking approval of diroximel fumarate under the 505(b)(2) regulatory pathway, and the NDA submission includes data from EVOLVE-1, a Phase 3 pivotal trial that evaluated long-term safety in relapsing-remitting MS (RRMS) with approximately 700 patients dosed with diroximel fumarate. If approved, Biogen intends to market diroximel fumarate under the brand name VUMERITY™. This name has been conditionally accepted by the FDA and will be confirmed upon approval. “Diroximel fumarate was designed to provide patients with relapsing forms of multiple sclerosis a novel oral fumarate with a differentiated
SoftServe Documentary Receives “The Best Corporate Media of Ukraine 2018” Award17.12.2018 13:00 | Pressemelding
25th anniversary documentary takes prize in “The Best Corporate Movie” category AUSTIN, Texas, Dec. 17, 2018 (GLOBE NEWSWIRE) -- SoftServe, a leading digital authority and consulting company, announces the Ukrainian Association of Corporate Media, a public organization uniting professionals in the field of marketing, PR, journalism, and advertising, recognized SoftServe in its annual competition – “The Best Corporate Media of Ukraine 2018.” SoftServe’s 25th anniversary documentary took second place in the “The Best Corporate Movie Category.” The documentary honors the company’s 25th anniversary with an inside look at how SoftServe evolved over the past quarter century to become a leading digital authority. In the documentary, SoftServe’s founders and leadership share their inspiring stories and highlight the company’s achievements over the years. “It is a great honor to receive this recognition from the Ukrainian Association of Corporate Media for our 25th anniversary documentary,” sai
Bombardier to supply a further 20 FLEXITY trams to Karlsruhe17.12.2018 10:00 | Pressemelding
Albtal-Verkehrs-Gesellschaft expands its fleet to 62 trams The dual-system vehicles operate on both the tram network and regional railway network BERLIN, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Global mobility solution provider Bombardier Transportation received a call-off order from Albtal-Verkehrs-Gesellschaft mbH (AVG), the transport company of the Alb valley region in southwest Germany, for the delivery of 20 further dual-system BOMBARDIER FLEXITY trams. This third order is based on a framework agreement for a total of 75 vehicles from 2009. The order is valued at approximately 87 million euro ($98 million US). The vehicles will be delivered between May 2020 and March 2021. "Striving to provide attractive local transport services, we have decided to order 20 additional dual-system vehicles from Bombardier Transportation. This will allow us to purposefully enlarge our vehicle fleet offering high-quality standards to our passengers," said Dr. Alexander Pischon, CEO of Albtal-Verkehrs-Gesel
DalCor Announces Completion of Patient Enrollment in dal-GenE, the First Phase 3 Precision Medicine Cardiovascular Outcomes Trial in Coronary Heart Disease17.12.2018 09:00 | Pressemelding
LONDON and MONTREAL, Dec. 17, 2018 (GLOBE NEWSWIRE) -- DalCor today announced the completion of patient enrollment in the dal-GenE study, the first Phase 3 precision medicine cardiovascular outcomes trial in coronary heart disease. The dal-GenE study is evaluating the efficacy of the CETP inhibitor dalcetrapib to reduce clinical cardiovascular events in patients with the AA ADCY9 genotype who have had a recent acute coronary syndrome (ACS). The study has enrolled over 6,000 patients and is being conducted in 680 sites in 32 countries. “The accelerated enrollment of patients in the dal-GenE study reflects the scientific enthusiasm and commitment among the medical community to bring the right medicine to the right patient,” said Dr. Jean-Claude Tardif from the Montreal Heart Institute. “ADCY9 genetic testing to identify the appropriate patients for treatment with dalcetrapib has the potential to provide a genetically targeted therapy to improve clinical outcomes. This approach could pave